Andrea S. Blevins Primeau, PhD, MBA

In the platinum-pretreated cohort, the objective response rate was 28%.

The 2-year actuarial rate of local recurrence was 4.8%.

Thirty-one percent of hospitals had ATRA immediately available.

Patients with liver metastases did not respond to checkpoint inhibitors.

The genomic-adjusted radiation dose (GARD) model predicts outcomes of radiotherapy.

Avelumab did not improve progression-free survival when given concurrently with chemotherapy or as maintenance.

Researchers analyzed recent trends in cervical cancer incidence and mortality and made predictions for the next 15 years.

The disparity is due to the greater prevalence of fibroids and nonendometrioid histologic type in Black women, according to researchers.

RSK4-targeting floxacins could boost the efficacy of chemotherapy.

The findings support current management strategies for cancer patients, according to researchers.